使用高压挤出生产的红细胞微粒可增强初级和二级血静
Snigdha Sama1, Sunjoo Cho1, Ashish K Rehni1
1Department of Neurology, Peritz Scheinberg Cerebral Vascular Disease Research Laboratories, University of Miami Miller School of Medicine, 1600 NW 10th Ave RMSB #7046, Miami, FL, 33136, USA.
Pharmacological reports : PR
|January 8, 2025
概括
红细胞衍生微粒 (RMPs) 通过促进血小板聚合来增强初级血静. 此外,RMP还通过缩短特定因子缺陷等离子体的凝血时间来改善二次静血.
科学领域:
- 血液学 血液学 血液学
- 生物医学工程 生物医学工程
背景情况:
- 目前的过度出血治疗有显著的并发症.
- 红细胞衍生微粒 (RMP) 显示出作为具有良好的安全性概况的静血剂的前景.
- 在血液静止中RMPs的精确机制需要进一步研究.
研究的目的:
- 为了阐明RMPs在初级和二级静血中作用的机制.
- 评估RMP对血小板聚合和血液凝结的影响.
- 确定RMP是否影响特定的凝血因子通路.
主要方法:
- 使用抑制剂 (eptifibatide,ticagrelor) 的血小板聚合计用于评估初级血液静止.
- 用因子缺陷等离子体 (VII,VIII,IX,XI,XII) 进行血小板造影用于二次静血评估.
- 使用高压挤出制备了RMP.
主要成果:
- RMP显著增强了原诱导的血小板聚合.
- 在有血小板抑制剂的情况下,RMP对血小板聚合的影响并不显著.
- 在缺乏因子VII,VIII,IX和XI的血中,RMP显著降低了凝血时间,但在缺乏因子VII,VIII,IX和XI的血中并没有显著降低凝血时间.
结论:
- RMPs有效地增强了原发性血液静止.
- RMPs有助于二次静血的两个途径.
- RMPs可能通过血小板受体起作用,并影响多种凝血因子.
相关概念视频
Structure and Function of Platelets
974
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
974
Extrinsic and Intrinsic Pathways of Hemostasis
5.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.3K
Formation of the Platelet Plug
4.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
4.2K
Introduction to Hemostasis
5.4K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.4K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
607
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
607


